Chandana Malakar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chandana Malakar has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Suresh Deka
Environmental Biotechnology Laboratory, Life Science Division, Institute of Advanced Study in Science and Technology, Guwahati, India
5 shared publications Mohan Chandra Kalita
Department of Biotechnology, Gauhati University, Jalukbari, Guwahati, 781014, Assam, India
3 shared publications- Ashis Kumar Mukherjee
Institute of Advanced Study in Science & Technology
2 shared publications Bhaswati Kashyap
Chemical Biology Laboratory I, Life Science Division, Institute of Advanced Study in Science and Technology, Paschim Boragaon, Guwahati, 781035, Assam, India
2 shared publicationsSuresh Deka
Environmental Biotechnology Laboratory, Life Science Division Institute of Advanced Study in Science and Technology Guwahati India
2 shared publicationsAnushree Roy
Life Science Division, Institute of Advanced Study in Science and Technology, Garchuk, Guwahati, India
1 shared publication
Latest Publications
- 22 November 2025
- Published by Springer Nature in International Microbiology
- Vol. 28 (8) , 3173-3183
A potent biosurfactant producing bacterial endophyte isolated from root gall of lady’s finger (Abelmoschus esculentus)
An endophytic bacterium having the capability to produce biosurfactant was isolated from the root gall of Lady’s finger (Abelmoschus esculentus). The stain reduces the surface tension of the culture media from 50.8mN to 30.8mN in 24 h and produces 3.3 g/L of biosurfactant at 48 h of incubation using glucose as a carbon source. It was revealed from the characterization of the biosurfactant that the strain produces a lipopeptide type of biosurfactant and the main component of the lipopeptide was surfactin. The bacterial strain was further characterized through molecular technique and identified as Providencia vermicola which was designated as strain SCL1. The biosurfactant produced by the strain was found to exhibit efficient antifungal activities against phytopathogenic fungi Colletotrichum gleoisporoides, Sclerotinium sclerotiorum, and Corynespora cassicolla. This is the first report that an endophytic bacterium Providencia vermicola can produce lipopeptide biosurfactant having antifungal properties against certain phytopathogenic fungi.
- 22 November 2025
- Published by Springer Nature in International Microbiology
- Vol. 28 (8) , 3173-3183
A potent biosurfactant producing bacterial endophyte isolated from root gall of lady’s finger (Abelmoschus esculentus)
An endophytic bacterium having the capability to produce biosurfactant was isolated from the root gall of Lady’s finger (Abelmoschus esculentus). The stain reduces the surface tension of the culture media from 50.8mN to 30.8mN in 24 h and produces 3.3 g/L of biosurfactant at 48 h of incubation using glucose as a carbon source. It was revealed from the characterization of the biosurfactant that the strain produces a lipopeptide type of biosurfactant and the main component of the lipopeptide was surfactin. The bacterial strain was further characterized through molecular technique and identified as Providencia vermicola which was designated as strain SCL1. The biosurfactant produced by the strain was found to exhibit efficient antifungal activities against phytopathogenic fungi Colletotrichum gleoisporoides, Sclerotinium sclerotiorum, and Corynespora cassicolla. This is the first report that an endophytic bacterium Providencia vermicola can produce lipopeptide biosurfactant having antifungal properties against certain phytopathogenic fungi.
- 29 November 2024
- Published by Springer Nature in BioNanoScience
- Vol. 15 (1) , 1-10
Synthesis, Characterization, and Evaluation of Antimicrobial Efficacy of Sophorolipid-Coated Zinc Oxide Nanoparticles
- 29 November 2024
- Published by Springer Nature in BioNanoScience
- Vol. 15 (1) , 1-10
Synthesis, Characterization, and Evaluation of Antimicrobial Efficacy of Sophorolipid-Coated Zinc Oxide Nanoparticles
- 14 August 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 195, 106855
Antibiofilm and wound healing efficacy of rhamnolipid biosurfactant against pathogenic bacterium Staphylococcus aureus
- 14 August 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 195, 106855
Antibiofilm and wound healing efficacy of rhamnolipid biosurfactant against pathogenic bacterium Staphylococcus aureus
- 14 April 2023
- Published by Wiley in Journal of Basic Microbiology
- Vol. 63 (7) , 746-758
A biosurfactant‐producing novel bacterial strain isolated from vermicompost having multiple plant growth‐promoting traits
The nutrient‐rich vermicompost which is used as manure for the growth and development of plants is rich in microbial flora. These microbes protect the plants against several infectious pathogenic microbes. As certain microbes are known to produce biosurfactants as metabolites, an investigation was carried out to isolate biosurfactant‐producing bacterial strains from vermicompost with the efficient antifungal property. From the study, it was revealed that biosurfactant‐producing bacterial strains are present in the vermicompost. A total of nine bacterial strains were isolated from the vermicompost. Among them, one most efficient biosurfactant‐producing bacterial strains with antifungal properties have been screened. After molecular characterization of the isolated strain, it was revealed that the bacterial strain is Bacillus licheniformis strain SCV1. The strain produces 3.4 ± 0.1 g/L of crude biosurfactant, which when column purified yields 3.1 ± 0.1 g/L of biosurfactant. The biosurfactant exhibited excellent emulsifying activity (E24) of 96.56% against crude oil. The produced biosurfactant was identified as a lipopeptide consisting of a mixer of surfactin and iturin. Furthermore, the biosurfactant exhibited significant antifungal activity against a wide range of phytopathogens, showing 76.3% inhibition against Sclerotinia sclerotiorum, 53% inhibition against Colletotrichum gloeosporioides, 51% against Fusarium verticillioides, and 36% against Corynespora cassicolla. Along with antifungal activities, the stain was found to exhibit multiple plant growth‐promoting traits. This study, thus indicates that vermicompost might contain biosurfactant‐producing microbes which can render protection to the plant against various phytopathogens by the production of biosurfactants and can also stimulate plant growth.
- 14 April 2023
- Published by Wiley in Journal of Basic Microbiology
- Vol. 63 (7) , 746-758
A biosurfactant‐producing novel bacterial strain isolated from vermicompost having multiple plant growth‐promoting traits
The nutrient‐rich vermicompost which is used as manure for the growth and development of plants is rich in microbial flora. These microbes protect the plants against several infectious pathogenic microbes. As certain microbes are known to produce biosurfactants as metabolites, an investigation was carried out to isolate biosurfactant‐producing bacterial strains from vermicompost with the efficient antifungal property. From the study, it was revealed that biosurfactant‐producing bacterial strains are present in the vermicompost. A total of nine bacterial strains were isolated from the vermicompost. Among them, one most efficient biosurfactant‐producing bacterial strains with antifungal properties have been screened. After molecular characterization of the isolated strain, it was revealed that the bacterial strain is Bacillus licheniformis strain SCV1. The strain produces 3.4 ± 0.1 g/L of crude biosurfactant, which when column purified yields 3.1 ± 0.1 g/L of biosurfactant. The biosurfactant exhibited excellent emulsifying activity (E24) of 96.56% against crude oil. The produced biosurfactant was identified as a lipopeptide consisting of a mixer of surfactin and iturin. Furthermore, the biosurfactant exhibited significant antifungal activity against a wide range of phytopathogens, showing 76.3% inhibition against Sclerotinia sclerotiorum, 53% inhibition against Colletotrichum gloeosporioides, 51% against Fusarium verticillioides, and 36% against Corynespora cassicolla. Along with antifungal activities, the stain was found to exhibit multiple plant growth‐promoting traits. This study, thus indicates that vermicompost might contain biosurfactant‐producing microbes which can render protection to the plant against various phytopathogens by the production of biosurfactants and can also stimulate plant growth.
- 26 January 2023
- Published by Springer Nature
- p. 481-501
Role of Biosurfactants in Biofilm Prevention and Disruption
- 26 January 2023
- Published by Springer Nature
- p. 481-501
Role of Biosurfactants in Biofilm Prevention and Disruption
- 31 October 2022
- Published by Wiley in Experimental Dermatology
- Vol. 32 (2) , 154-164
Wound healing efficacy of rhamnolipid‐coated zinc oxide nanoparticle along with its in vivo antibacterial efficacy against Staphylococcus aureus
Rhamnolipids are microbial metabolites with antibacterial efficacies, which can be further boosted through the application of nanobiotechnology. In this study, the efficacy of rhamnolipid‐coated zinc oxide nanoparticles (ZnRL) has been studied for their wound healing efficacy as well as in vivo antibacterial efficacy. Thus, this study evaluates the efficacy of ZnRL to heal an excised infected wound, which was compared with the healing efficacy of rhamnolipid and clindamycin. The study revealed that rhamnolipid‐coated zinc oxide nanoparticles possess promising wound healing efficacy with prominent antibacterial activity in the rat model. Prominent wound healing in a Staphylococcus aureus infected excised wound was observed on the 5th day of the treatment when the wound site was treated with 100 μl of 0.5 mg/ml of ZnRL. This concentration of ZnRL was found to exhibit efficient antibacterial activity against the pathogen, thereby decreasing the amount of pathogen in the wound site. ZnRL exhibited efficient wound contraction, thereby decreasing the size of the wound prominently in 5 days. Histological study revealed efficient tissue remodelling in ZnRL‐treated skin which resulted in rapid formation of the epidermis and recruitment of various dermal cells within the 5th day of treatment. The study also revealed the non‐cytotoxic effect of the nanoparticles in fibroblast cell line L929 and the non‐haemolytic effect against blood cells, indicating its potential in pharmaceuticals.
- 31 October 2022
- Published by Wiley in Experimental Dermatology
- Vol. 32 (2) , 154-164
Wound healing efficacy of rhamnolipid‐coated zinc oxide nanoparticle along with its in vivo antibacterial efficacy against Staphylococcus aureus
Rhamnolipids are microbial metabolites with antibacterial efficacies, which can be further boosted through the application of nanobiotechnology. In this study, the efficacy of rhamnolipid‐coated zinc oxide nanoparticles (ZnRL) has been studied for their wound healing efficacy as well as in vivo antibacterial efficacy. Thus, this study evaluates the efficacy of ZnRL to heal an excised infected wound, which was compared with the healing efficacy of rhamnolipid and clindamycin. The study revealed that rhamnolipid‐coated zinc oxide nanoparticles possess promising wound healing efficacy with prominent antibacterial activity in the rat model. Prominent wound healing in a Staphylococcus aureus infected excised wound was observed on the 5th day of the treatment when the wound site was treated with 100 μl of 0.5 mg/ml of ZnRL. This concentration of ZnRL was found to exhibit efficient antibacterial activity against the pathogen, thereby decreasing the amount of pathogen in the wound site. ZnRL exhibited efficient wound contraction, thereby decreasing the size of the wound prominently in 5 days. Histological study revealed efficient tissue remodelling in ZnRL‐treated skin which resulted in rapid formation of the epidermis and recruitment of various dermal cells within the 5th day of treatment. The study also revealed the non‐cytotoxic effect of the nanoparticles in fibroblast cell line L929 and the non‐haemolytic effect against blood cells, indicating its potential in pharmaceuticals.
- 13 October 2021
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 37 (11) , 1-14
Synthesis, characterization, and evaluation of antibacterial efficacy of rhamnolipid-coated zinc oxide nanoparticles against Staphylococcus aureus
The antimicrobial efficacy of rhamnolipid is well established against a wide range of pathogens. However little is known about the enhancement of antimicrobial efficacy of rhamnolipid in the form of nanoparticles. With a curiosity of enhancing antimicrobial activity, a study has been carried out to evaluate the antimicrobial efficacy of rhamnolipid-coated zinc oxide nanoparticles. The zinc oxide nanoparticles were synthesized with rhamnolipid, produced by Pseudomonas aeruginosa JS29. The rhamnolipid-coated zinc oxide nanoparticles were characterized by FTIR, XRD, TGA, TEM, and SAED. The antimicrobial and antibiofilm efficacy of the nanoparticles was evaluated against Staphylococcus aureus MTCC 96. FTIR, XRD, TEM, and SAED analyses confirmed that the nanoparticles contain both rhamnolipid and zinc as constituents and are polycrystalline with sizes ranging from 40 to 50 nm. At a concentration of 250 µg/ml, rhamnolipid-coated zinc oxide nanoparticles exhibited 80% growth inhibition of the pathogen. Again, at the same concentration, the nanoparticle was observed to inhibit 78% of biofilm formation while disrupting 100% of preformed biofilm. The nanoparticles demonstrated an enhanced inhibitory and antibiofilm efficacy against the pathogen compared to the individual effect of both rhamnolipid and zinc oxide nanoparticles. With the established non-toxicity of rhamnolipid-coated zinc oxide nanoparticles in fibroblast cell lines, the nanoparticles could be a promising pharmaceutical alternative. Graphic abstract
- 13 October 2021
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 37 (11) , 1-14
Synthesis, characterization, and evaluation of antibacterial efficacy of rhamnolipid-coated zinc oxide nanoparticles against Staphylococcus aureus
The antimicrobial efficacy of rhamnolipid is well established against a wide range of pathogens. However little is known about the enhancement of antimicrobial efficacy of rhamnolipid in the form of nanoparticles. With a curiosity of enhancing antimicrobial activity, a study has been carried out to evaluate the antimicrobial efficacy of rhamnolipid-coated zinc oxide nanoparticles. The zinc oxide nanoparticles were synthesized with rhamnolipid, produced by Pseudomonas aeruginosa JS29. The rhamnolipid-coated zinc oxide nanoparticles were characterized by FTIR, XRD, TGA, TEM, and SAED. The antimicrobial and antibiofilm efficacy of the nanoparticles was evaluated against Staphylococcus aureus MTCC 96. FTIR, XRD, TEM, and SAED analyses confirmed that the nanoparticles contain both rhamnolipid and zinc as constituents and are polycrystalline with sizes ranging from 40 to 50 nm. At a concentration of 250 µg/ml, rhamnolipid-coated zinc oxide nanoparticles exhibited 80% growth inhibition of the pathogen. Again, at the same concentration, the nanoparticle was observed to inhibit 78% of biofilm formation while disrupting 100% of preformed biofilm. The nanoparticles demonstrated an enhanced inhibitory and antibiofilm efficacy against the pathogen compared to the individual effect of both rhamnolipid and zinc oxide nanoparticles. With the established non-toxicity of rhamnolipid-coated zinc oxide nanoparticles in fibroblast cell lines, the nanoparticles could be a promising pharmaceutical alternative. Graphic abstract